EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Towards optimizing carbapenem selection in stewardship strategies: a prospective propensity score-matched study of ertapenem versus class 2 carbapenems for empirical treatment of third-generation cephalosporin-resistant Enterobacterales bacteraemia

Vasin Vasikasin, Bawornnan Panuvatvanich, Timothy M Rawson, Alison H Holmes, Worapong Nasomsong

Journal of Antimicrobial Chemotherapy · 2023

DOI: 10.1093/jac/dkad165 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2023. Verfasst von Vasin Vasikasin und 4 weiteren Autor:innen. Beteiligte Einrichtung: NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, Hammersmith Hospital,…. Hauptthemen laut MEDLINE: Shock, Septic, Bacteremia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Department of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Third-generation cephalosporin-resistant Enterobacterales (3GCRE) are increasing in prevalence, leading to greater carbapenem consumption. Selecting ertapenem has been proposed as a strategy to reduce carbapenem resistance development. However, there are limited data for the efficacy of empirical ertapenem for 3GCRE bacteraemia.

Objectives

To compare the efficacy of empirical ertapenem and class 2 carbapenems for the treatment of 3GCRE bacteraemia.

Methods

A prospective non-inferiority observational cohort study was performed from May 2019 to December 2021. Adult patients with monomicrobial 3GCRE bacteraemia receiving carbapenems within 24 h were included at two hospitals in Thailand. Propensity scores were used to control for confounding, and sensitivity analyses were performed in several subgroups. The primary outcome was 30 day mortality. This study is registered with clinicaltrials.gov (NCT03925402).

Results

Empirical carbapenems were prescribed in 427/1032 (41%) patients with 3GCRE bacteraemia, of whom 221 received ertapenem and 206 received class 2 carbapenems. One-to-one propensity score matching resulted in 94 pairs. Escherichia coli was identified in 151 (80%) of cases. All patients had underlying comorbidities. Septic shock and respiratory failure were the presenting syndromes in 46 (24%) and 33 (18%) patients, respectively. The overall 30 day mortality rate was 26/188 (13.8%). Ertapenem was non-inferior to class 2 carbapenems in 30 day mortality (12.8% versus 14.9%; mean difference −0.02; 95% CI: −0.12 to 0.08). Sensitivity analyses were consistent regardless of aetiological pathogens, septic shock, source of infection, nosocomial acquisition, lactate levels or albumin levels.

Conclusions

Ertapenem may be of comparable efficacy to class 2 carbapenems in the empirical treatment of 3GCRE bacteraemia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Shock, SepticBacteremiaAdultHumansErtapenemCarbapenemsAnti-Bacterial AgentsPropensity ScoreProspective StudiesEscherichia coliCephalosporins

Substanzen

ErtapenemCarbapenemsAnti-Bacterial AgentsCephalosporins

Autor:innen und Institutionen

  • NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, Hammersmith Hospital, Du Cane Road, Acton, London, W12 0NN, UK.
  • Department of Internal Medicine, Phramongkutklao Hospital, 315 Ratchavithi Rd, Ratchadhevi, Bangkok, 10400, Thailand.
  • Faculty of Health and Life Sciences, University of Liverpool, Liverpool, L69 7TX, UK.

Förderung

  • Department of Health

Zitieren

APA

Vasikasin, V., Panuvatvanich, B., Rawson, T. M., Holmes, A. H., & Nasomsong, W. (2023). Towards optimizing carbapenem selection in stewardship strategies: a prospective propensity score-matched study of ertapenem versus class 2 carbapenems for empirical treatment of third-generation cephalosporin-resistant Enterobacterales bacteraemia. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkad165

Vancouver

Vasikasin V, Panuvatvanich B, Rawson TM, Holmes AH, Nasomsong W. Towards optimizing carbapenem selection in stewardship strategies: a prospective propensity score-matched study of ertapenem versus class 2 carbapenems for empirical treatment of third-generation cephalosporin-resistant Enterobacterales bacteraemia. Journal of Antimicrobial Chemotherapy. 2023. doi:10.1093/jac/dkad165

BibTeX
@article{Vasikasin2023,
  author = {Vasikasin, Vasin and Panuvatvanich, Bawornnan and Rawson, Timothy M and Holmes, Alison H and Nasomsong, Worapong},
  title = {Towards optimizing carbapenem selection in stewardship strategies: a prospective propensity score-matched study of ertapenem versus class 2 carbapenems for empirical treatment of third-generation cephalosporin-resistant Enterobacterales bacteraemia},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2023},
  doi = {10.1093/jac/dkad165}
}
Kostenlos starten →